Lexicon Pharmaceuticals (LXRX) Cash from Investing Activities (QoQ) (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Lexicon Pharmaceuticals |
804.48 Mn |
633.82 Mn |
20.99 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-1,554.72% |
| Dec 31, 2025 |
-90.73% |
| Sep 30, 2025 |
236.66% |
| Jun 30, 2025 |
-61.85% |
| Mar 31, 2025 |
-24.43% |
| Dec 31, 2024 |
0.43% |
| Sep 30, 2024 |
533.90% |
| Jun 30, 2024 |
88.82% |
| Mar 31, 2024 |
-312.39% |
| Dec 31, 2023 |
231.97% |
| Sep 30, 2023 |
47.29% |
| Jun 30, 2023 |
-716.95% |
| Mar 31, 2023 |
-49.98% |
| Dec 31, 2022 |
131.32% |
| Sep 30, 2022 |
-465.62% |
| Jun 30, 2022 |
-209.62% |
| Mar 31, 2022 |
-172.31% |
| Dec 31, 2021 |
1,624.00% |
| Sep 30, 2021 |
-102.83% |
| Jun 30, 2021 |
179.77% |
